Recommended content

How could new attorney general impact cannabis rescheduling? (Newsletter: April 3, 2026)

FDA CBD memo; MA anti-marijuana initiative faces lawsuit; DC mayor’s cannabis drinks plan; TX medical marijuana licenses; VA prepares for legal sales

Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.

Your support makes Marijuana Moment possible…

Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.

If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment

/ TOP THINGS TO KNOW

Food and Drug Administration Commissioner Marty Makary issued a guidance memo saying the agency “does not intend to enforce” certain federal laws against hemp-derived CBD products covered under a new Medicare initiative if they meet specific requirements.

If President Donald Trump replaces outgoing Attorney General Pam Bondi with Lee Zeldin, as he is reportedly considering, it could impact the marijuana rescheduling process—as Zeldin

Read full article on Marijuana Moment

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Moment
Source

More news